NEK6 Regulates Redox Balance and DNA Damage Response in DU-145 Prostate Cancer Cells
Authors:
- Isadora Carolina Betim PavanIPIsadora Carolina Betim Pavan
- Fernanda Luisa BaseiFBFernanda Luisa Basei
- Matheus Brandemarte SeverinoMSMatheus Brandemarte Severino
- Ivan Rosa e SilvaISIvan Rosa e Silva
- Luidy Kazuo IssayamaLILuidy Kazuo Issayama
- Mariana Camargo Silva ManciniMMMariana Camargo Silva Mancini
- Mariana Marcela GóisMGMariana Marcela Góis
- Luiz Guilherme Salvino da SilvaLuiz Guilherme Salvino da Silva
- Rosangela Maria Neves BezerraRBRosangela Maria Neves Bezerra
- Fernando Moreira SimabucoFSFernando Moreira Simabuco
- Jörg KobargJKJörg Kobarg
Open Access
Abstract
NEK6 is a central kinase in developing castration-resistant prostate cancer (CRPC). However, the pathways regulated by NEK6 in CRPC are still unclear. Cancer cells have high reactive oxygen species (ROS) levels and easily adapt to this circumstance and avoid cell death by increasing antioxidant defenses. We knocked out the NEK6 gene and evaluated the redox state and DNA damage response in DU-145 cells. The knockout of NEK6 decreases the clonogenic capacity, proliferation, cell viability, and mitochondrial activity. Targeting the NEK6 gene increases the level of intracellular ROS; decreases the expression of antioxidant defenses (SOD1, SOD2, and PRDX3); increases JNK phosphorylation, a stress-responsive kinase; and increases DNA damage markers (p-ATM and γH2AX). The exogenous overexpression of NEK6 also increases the expression of these same antioxidant defenses and decreases γH2AX. The depletion of NEK6 also induces cell death by apoptosis and reduces the antiapoptotic Bcl-2 protein. NEK6-lacking cells have more sensitivity to cisplatin. Additionally, NEK6 regulates the nuclear localization of NF-κB2, suggesting NEK6 may regulate NF-κB2 activity. Therefore, NEK6 alters the redox balance, regulates the expression of antioxidant proteins and DNA damage, and its absence induces the death of DU-145 cells. NEK6 inhibition may be a new strategy for CRPC therapy.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/03489-1, 2018/14818-9, 2016/06457-0, 2018/08391-2, 2018/05350-3, 2020/16265-7, 2020/13660-2, 2020/09527-5, 2020/08684-0, 2019/25582-9, 2018/13775-4)
- fellowships (2017/03489-1, 2018/14818-9, 2016/06457-0, 2018/08391-2, 2018/05350-3, 2020/16265-7, 2020/13660-2, 2020/09527-5, 2020/08684-0, 2019/25582-9, 2018/13775-4)
This publication has 84 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- Induction of reactive oxygen species generation inhibits epithelial–mesenchymal transition and promotes growth arrest in prostate cancer cellsMolecular Carcinogenesis, 2013
- Mitochondrial Network Determines Intracellular ROS Dynamics and Sensitivity to Oxidative Stress through Switching Inter-Mitochondrial MessengersPLOS ONE, 2011
- Crosstalk of reactive oxygen species and NF-κB signalingCell Research, 2010
- Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosisCell Death & Differentiation, 2010
- A minority of foci or pan-nuclear apoptotic staining of γH2AX in the S phase after UV damage contain DNA double-strand breaksProceedings of the National Academy of Sciences, 2010
- NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpointNature Cell Biology, 2009
- The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and CytokinesisMolecular and Cellular Biology, 2009
- Regulation of Cu/Zn-Superoxide Dismutase Expression via the Phosphatidylinositol 3 Kinase/Akt Pathway and Nuclear Factor-κBThe Journal of Neuroscience, 2004